known to be an important immunomodulatory mediator and elicits a broad array of physiological or pathophysiological responses by acting via 4 G protein-coupled receptors, which are functionally expressed on many immune cells involved in inflammatory skin diseases [10] [11] [12] [13] [14] .
The expression of the H1R and H4R at the protein level on NK cells has been described previously. Moreover, migration of NK cells induced by histamine has been shown. Thioperamide, an antagonist of the H3R and H4R, abolished this effect. Since NK cells lack the expression of the H3R, the chemotaxis of NK cells was specifically attributed to the H4R [11] .
However, immunomodulatory effects of histamine via the H4R on NK cells have not been described until now; therefore, we investigated the influence of the H4R on gene expression in NK cells in an unbiased approach.
Materials and Methods

NK Cell Isolation
Peripheral blood mononuclear cells were separated from buffy coats by density gradient centrifugation on Lymphoprep (Fresenius Kabi Norge AS, Oslo, Norway) as described previously [12] . Untouched CD3-and CD56+ NK cells were isolated by negative selection using magnetic beads, and the purity of the enriched NK cells was evaluated according to the manufacturer's instructions (Miltenyi Biotech Inc., Bergisch-Gladbach, Germany).
Microarray-Based mRNA Expression Analysis (Dual Color Mode)
Isolated NK cells were resuspended at 5 × 10 5 cells/200 μl in modified Iscove medium containing 20 ng/ml IL-2. After 24 h, the cells were stimulated with ST1006 10 -5 M (H4R agonist, Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Germany) [13] or left unstimulated for 6 h. RNA was isolated using the Qiagen RNeasy Microkit (Qiagen, Hilden, Germany).
The mRNA expression profiling was performed using the Whole Human Genome Oligo Microarray V2 (G4845A, ID 026652, Agilent Technologies) which contains 44,495 oligonucleotide probes covering roughly 27,390 human transcripts (a detailed protocol can be retrieved upon request). H4R-stimulated and -unstimulated samples, each pooled from 2 healthy donors, were labeled with different fluorophores (Alexa555 vs. Alexa647) and were cohybridized onto 1 microarray. A second microarray experiment, designed in a dye-swap approach, containing pooled samples from 2 further donors, was additionally conducted.
NK Cell Stimulation
Isolated NK cells were resuspended at 5 × 10 5 cells/200 μl in modified Iscove medium containing 20 ng/ml IL-2. After 24 h, the cells were stimulated with histamine 10 -5 M (Alk-Scherax, Wedel, Germany) or ST1006 10 -5 M for 6 h for quantitative PCR and 24 h for ELISA or were left unstimulated. For blocking experiments, the selective H4R antagonist JNJ7777120 10 -5 M ( Sigma-Aldrich, Deisenhofen, Germany) was added 30 min before stimulation.
LightCycler Quantitative Real-Time PCR
The isolation of RNA from NK cells, the reverse transcription and the LightCycler quantitative real-time PCR with primers designed by Qiagen were performed as described previously [12] .
ELISA
Cell-free supernatants were used to detect the human chemokines CCL3 and CCL4 in ELISA, performed according to the manufacturer's instructions (R&D Systems, San Diego, Calif., USA).
Statistics
For statistical analyses, the software GraphPad Prism version 5.0 was used. Wilcoxon's matched-pairs test was performed, and the medians are shown in figure 2 . A p value <0.05 was regarded as statistically significant.
Results
In a previous study, the expression of the H1R and H4R in human NK cells was already determined at the protein level [11] . Here, we detected the expression of the H1R, H2R and H4R but not H3R at the mRNA level on purified human NK cells ( fig. 1 a) by real-time LightCycler PCR ( fig. 1 b) .
In order to identify genes which were regulated via the H4R, a comprehensive analysis of the mRNA expression of H4R-stimulated versus nonstimulated human NK cells was performed. Applying different filter criteria revealed only few genes to be differentially regulated upon H4R stimulation. Furthermore, observed differences in mRNA expression levels turned out to be just moderate. Only 17 out of 27,390 analyzed transcripts were differentially expressed after H4R stimulation, assessed by lowstringency filter criteria. Table 1 shows a repertory of these genes.
Since these genes are not of major known impact on NK cell functions, we selected genes of cytokines and chemokines which were analyzed in the same mRNA array and are known for having a role in NK cell activation as depicted in figure 2 a. The mRNA of TNF-α, CCL3, CCL4 and CCL3L3 showed slightly increased expression levels upon stimulation via H4R ( fig. 2 a) . Of note, the homology in the complete gene region in chromosome 17q12 of CCL3L3 and CCL3 is 92.1% and in the exonic sequences 95.7%, respectively [15] .
We next analyzed the mRNA expression of TNF-α, CCL3, CCL4 and CCL3L3 in NK cells, obtained from multiple donors, by quantitative real-time PCR. We ob-served a significant upregulation of the mRNA expression of CCL4 and CCL3 upon stimulation with histamine or ST1006 ( fig. 2 b-d) , whereas no change of the mRNA expression of CCL3L3 and TNF-α was detected (data not shown). To analyze the time dependence of the H4R-induced CCL3 mRNA expression, NK cells were treated either with histamine or ST1006 for different time periods. CCL3 mRNA expression increased significantly after 4, 6 and 8 h with a peak at 6 h ( fig. 2 c) . The maximum mRNA expression level after 6 h in response to the H4R agonist ST1006 was also shown for CCL4 by investigating a smaller sample size (see online suppl. fig.  S1d ; for all online suppl. material, see www.karger.com/ doi/10.1159/000381340). We could also show that stimulation with ST1006 led to a significant upregulation of CCL3 at the protein level ( fig. 2 e) . The increase of CCL3 protein was selectively abrogated after blocking the H4R with the specific antagonist JNJ7777120. No regulation of CCL4 protein secretion was detected upon H4R stimulation (data not shown).
Interestingly it was observed that IL-2, which was added to the culture medium to activate the NK cells, represents a strong inducer of the CCL3 mRNA expression and protein production when compared to the nonactivated resting NK cells. In addition, IL-2 was also essential for the upregulation of CCL3 mRNA expression and protein production by histamine or ST1006 (see online suppl. fig.  S1a-c) . As opposed to CCL3, the CCL4 mRNA expres- sion was not influenced by IL-2. However, in the same way the presence of IL-2 was essential for the upregulation of the CCL4 mRNA expression via the H4R (see online suppl. fig. S1d ). In addition, IL-2 upregulates CCL4 protein production (see online suppl. fig. S1e , f).
Discussion
Atopic dermatitis is a common inflammatory skin disease in which the role of the adaptive immune system, in particular of T lymphocytes, in the initiation and progression of the disease is well documented. NK cells, phenotypically characterized as CD3-and CD56+ lymphocytes, showed reduced frequency in the peripheral blood of atopic dermatitis patients. In contrast, their number is increased in the lesional skin of these patients [7] . Histamine, which is mainly released by activated mast cells, is known to be present in inflamed skin [8] . A previous study [11] has shown that histamine influences the migration of NK cells via the H4R but does not affect the cytotoxic capacity or the release of Ca 2+ from NK cells.
Here, we investigated for the first time the expression of the histamine receptors, in particular of the H4R, at mRNA level and evaluated the role of the H4R on gene expression in human NK cells. We could show that the H1R, H2R and H4R mRNA, but not the H3R mRNA, are expressed in human NK cells. Comprehensive mRNA expression profiling after H4R stimulation revealed only few genes to be differentially expressed. We focused our attention on selected targets, in particular the chemokines CCL3 and CCL4, which play a crucial role in the coordination of NK cell effector functions [16] . CCL3 and CCL4 showed increased mRNA expression levels in response to the H4R agonist in microarray analysis. These data were confirmed by subsequent mRNA and protein quantification from stimulated NK cells derived from multiple donors. These follow-up studies confirmed a significant upregulation of CCL3 and CCL4 mRNA expression in a time-dependent manner. Furthermore, we could show a significant upregulation only for CCL3 at the protein level in response to the H4R agonist, which was blocked by preincubation of the cells with a selective H4R antagonist, showing that the effect was specific for the H4R. Applied filter criteria were: n-fold change >1.5 (or <0.67); arithmetic mean of processed signal values >50; IsFeatNonUnifOL = 0 (all criteria to be fulfilled in both independent microarray experiments). The average nfold change from 2 experiments is given. The discrepancy between CCL4 mRNA and protein expression in response to H4R stimulation compared to the concomitant mRNA and protein expression of CCL3 may occur due to differential secondary posttranscriptional regulation of these genes.
The pronounced secretion of CCL3 upon H4R stimulation might contribute to the accumulation of various innate and adaptive immune cells to the distinct microenvironment. NK cells themselves also demonstrated increased chemotactic responses to CCL3. Moreover, CCL3 has been identified to promote the cytolytic activity of polyclonal human NK cells or NK cell clones [16] .
Taking into account these previous reports, our results suggest that the elevated expression levels of CCL3, which were mainly induced via activation of the H4R on NK cells, may exacerbate chronic inflammatory skin diseases by creating and maintaining the inflammatory response. Only samples where the nonstimulated (n.s.) control showed <1,500 pg/ml CCL3 protein were included in the study. * p < 0.05. * * p < 0.005 .
In conclusion, our study on human NK cells provides a further contribution toward understanding the function of the H4R in distinct lymphocyte populations. In previous studies [12, 17] , we showed inflammatory effects via the H4R on human CD4+ T cells and Th17 cells by upregulating the cytokines IL-31 or IL-17, respectively. In this regard, our findings here emphasize H4R antagonists as potential therapeutic tools to reduce the inflammatory response in allergic skin diseases.
